Vericel Corporation (VCEL)
18.91 x 1 50.51 x 1
Pre-market by (Cboe BZX)
38.74 -0.99 (-2.49%) 04/28/25 [NASDAQ]
18.91 x 1 50.51 x 1
Pre-market 38.70 -0.04 (-0.10%) 05:09 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | VCEL | BEAM | BLTE | ||
Company | Vericel Corporation | Beam Therapeutics Inc | Belite Bio Inc ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 40.01 | 19.59 | 58.23 | ||
High | 40.51 | 20.17 | 60.50 | ||
Low | 38.34 | 19.36 | 57.51 | ||
Last | 38.74 | 19.80 | 60.18 | ||
Change | -0.99 | +0.28 | +1.95 | ||
% Change | -2.49% | +1.43% | +3.35% | ||
Volume | 447,100 | 1,269,900 | 37,200 | ||
20-Day Average Volume | 559,520 | 2,955,415 | 38,690 | ||
Previous Close | 39.73 | 19.52 | 58.23 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 41.43 | 17.42 | 58.93 | ||
20-Day Raw Stochastic | 13.59% | 79.89% | 62.95% | ||
20-Day Relative Strength | 37.28% | 47.99% | 49.86% | ||
Weighted Alpha | -28.33 | -11.56 | +31.60 | ||
Today's Opinion | 88% Sell | 88% Sell | 8% Sell | ||
Previous Opinion | 88% Sell | 88% Sell | 40% Sell | ||
Last Month's Opinion | 56% Sell | 40% Sell | 72% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -5.21% since 04/21/25 | +8.55% since 04/21/25 | +10.04% since 04/21/25 | ||
Low | 38.34 on 04/28/25 | 18.34 on 04/22/25 | 54.62 on 04/22/25 | ||
High | 42.02 on 04/23/25 | 20.81 on 04/23/25 | 60.50 on 04/28/25 | ||
1-Month | |||||
%Chg | -12.94% since 03/28/25 | -10.85% since 03/28/25 | -9.78% since 03/28/25 | ||
Low | 37.76 on 04/08/25 | 13.52 on 04/07/25 | 49.00 on 04/09/25 | ||
High | 44.97 on 04/01/25 | 21.38 on 03/31/25 | 66.76 on 03/31/25 | ||
3-Month | |||||
%Chg | -35.55% since 01/28/25 | -21.62% since 01/28/25 | +1.76% since 01/28/25 | ||
Low | 37.76 on 04/08/25 | 13.52 on 04/07/25 | 49.00 on 04/09/25 | ||
High | 63.00 on 02/05/25 | 35.25 on 02/18/25 | 70.99 on 03/13/25 | ||
6-Month | |||||
%Chg | -15.16% since 10/28/24 | -11.41% since 10/28/24 | -11.23% since 10/28/24 | ||
Low | 37.76 on 04/08/25 | 13.52 on 04/07/25 | 49.00 on 04/09/25 | ||
High | 63.00 on 02/05/25 | 35.25 on 02/18/25 | 86.53 on 11/14/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,942,269 | 1,991,028 | 1,916,010 | ||
Shares Outstanding, K | 50,136 | 100,557 | 31,838 | ||
Annual Sales | 237,220,000 | 63,520,000 | 0 | ||
Annual Net Income | 10,360,000 | -376,740,000 | -36,140,000 | ||
Last Quarter Sales | 75,380,000 | 30,070,000 | 0 | ||
Last Quarter Net Income | 19,810,000 | -90,350,000 | -10,100,000 | ||
60-Month Beta | 1.61 | 2.02 | -1.52 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.38 on 02/27/25 | -1.09 on 02/25/25 | -0.32 on 03/17/25 | ||
Latest Earnings Date | 05/08/25 | 05/06/25 | 05/12/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | 02/04/14 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 220.72 | 0.00 | 0.00 |